Clinical Trials Browser

Phase 1 × Relapsed Solid Tumors × Other solid neoplasm × Clear all

NCT02596503 2022-02-15

A Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Relapsed Solid Tumors